| Literature DB >> 29875445 |
Olga Zurita Rendón1,2, Eric K Fredrickson2, Conor J Howard3,4, Jonathan Van Vranken2, Sarah Fogarty1,2, Neal D Tolley5, Raghav Kalia2,3,4, Beatriz A Osuna3,6, Peter S Shen2, Christopher P Hill2, Adam Frost7,8,9,10, Jared Rutter11,12.
Abstract
Eukaryotic cells employ the ribosome-associated quality control complex (RQC) to maintain homeostasis despite defects that cause ribosomes to stall. The RQC comprises the E3 ubiquitin ligase Ltn1p, the ATPase Cdc48p, Rqc1p, and Rqc2p. Upon ribosome stalling and splitting, the RQC assembles on the 60S species containing unreleased peptidyl-tRNA (60S:peptidyl-tRNA). Ltn1p and Rqc1p facilitate ubiquitination of the incomplete nascent chain, marking it for degradation. Rqc2p stabilizes Ltn1p on the 60S and recruits charged tRNAs to the 60S to catalyze elongation of the nascent protein with carboxy-terminal alanine and threonine extensions (CAT tails). By mobilizing the nascent chain, CAT tailing can expose lysine residues that are hidden in the exit tunnel, thereby supporting efficient ubiquitination. If the ubiquitin-proteasome system is overwhelmed or unavailable, CAT-tailed nascent chains can aggregate in the cytosol or within organelles like mitochondria. Here we identify Vms1p as a tRNA hydrolase that releases stalled polypeptides engaged by the RQC.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29875445 PMCID: PMC5989216 DOI: 10.1038/s41467-018-04564-3
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Vms1 physically and genetically interacts with the RQC. a, b Serial dilutions of indicated strains were spotted on media containing glucose or glucose supplemented with cycloheximide (CHX). EV empty vector. c Immunoprecipitation using anti-HA antibody in the strains rqc2∆ vms1∆ expressing Rqc2p and Vms1p-V5 (control) or Rqc2p-HA and Vms1p-V5. Immunoblotting of HA and V5 were used to identify Rqc2p and Vms1p, respectively. d Polysome profile of the rqc2∆ vms1∆ strain expressing Rqc2p-HA and Vms1p-V5 treated with CHX prior to fractionation using sucrose density centrifugation. The sedimentation of ribosomal particles was inferred from the A254 profile (40S, 60S, 80S, and polysomes) and the distribution of the 60S subunit was confirmed by immunoblotting of the ribosomal subunit, Rpl3p. Immunoblotting of HA and V5 was used to detect Rqc2p and Vms1p, respectively
Fig. 2Vms1p is required for resolving RQC substrates. a Fluorescence microscopy analysis of the indicated strains expressing the FLAG-GFPRz construct under the GPD promoter and the mitochondrial marker, mtRFP. b Flow cytometry quantifications of FLAG-GFP accumulation in the indicated strains. Median GFP intensity values are plotted (n = 3, mean ± s.e.m. ****P < 0.0001, The p value was calculated using unpaired Student’s t-test). c Immunoblot analysis of indicated strains expressing the FLAG-GFPRz construct. Immunoblotting of Flag was used to detect the accumulation of the stalled construct. Pgk1p was used as loading control. d Fluorescence microscopy analysis of the indicated strains expressing the Fum1-FLAG-GFPRz construct expressed from the FUM1 endogenous promoter and the mitochondrial marker, mtRFP
Fig. 3Vms1p is structurally homologous to tRNA hydrolases. a Domain structure of Vms1p. LRS leucine-rich sequence, ZnF zinc finger, MTD/eRFL mitochondrial targeting domain/eRF1-like, AnkR ankryin repeat, CC coil–coil, VIM VCP-interacting motif. Residues 188–417 represent the MTD/eRFL boundaries. b Structural alignment of Vms1p (left, 5WHG[31]) and eRF1p (middle, 3JAHii[35], residues 144–280). Dashed lines indicate connections made by residues that are not resolved in the Vms1p crystal structure. The GGQ (red) loop of eRF1p is ordered in the ribosome-bound structure shown here. c Sequence alignment of Vms1p and eRF1p. White letters with gray, black, or red background indicates similarity, identity, or GxxQ residues, respectively. d Sequence alignment of Vms1p orthologs across the GxxQ region. Coloring as in c. e, f Serial dilutions of indicated strains were spotted on media containing glucose or glucose supplemented with cycloheximide (CHX). EV empty vector
Fig. 4Vms1p exhibits tRNA hydrolase activity towards RQC substrates. a Time courses of S. cerevisiae in vitro translation (ScIVT) reactions prepared with a truncated mRNA (lacking a stop codon). Extract genotypes are indicated above. Peptides that have been CAT-tailed and released are denoted with a cat tail icon. b Quantification of peptidyl-tRNA species in a. Mean ± s.e.m.; n = 6. ****P < 0.0001. The p value was calculated using a two-way ANOVA. c Time courses of ScIVT reactions prepared as in a. d Quantification of peptidyl-tRNA species in c. Mean ± s.e.m., n = 8. ****P < 0.0001. The p value was calculated using a two-way ANOVA. e ScIVT reactions prepared as in a with a vms1Δ extract. At t = 15, buffer (−) or pure protein was added. Slopes indicate a titration series of decreasing protein concentrations (see Methods). FL full length Vms1, 1–417 N terminus through eRFL domain. f ScIVT reactions prepared as in a with a vms1Δ extract. At t = 15, buffer, WT (1–417) protein, or mutant (1–417) protein was added